newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference

UTRECHT, The Netherlands and PHILADELPHIA, Feb. 09, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ:LVTX), a clinical stage immuno-oncology company focused on developing its proprietary Gammabody™